The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms.

Panattoni LE., J Health Econ. 30(1):126-45. doi: 10.1016/j.jhealeco.2010.09.004. Epub 2010 Oct 8., 2011 Jan 01

Abstract

This purpose of this paper is to investigate the impact of Paragraph IV patent infringement decisions on brand drug pharmaceutical firms. Paragraph IV decisions determine whether a generic firm can enter before the period of exclusivity ends.

I construct a novel dataset of all Paragraph IV decisions and find that they disproportionately involve the highest revenue drugs, significant periods of patent protection, and a non-trivial portion of all brand drugs facing generic entry.

I also estimate the impact of Paragraph IV decisions on brand firm profitability and find they have large value consequences.

Pubmed Abstract

Pubmed AbstractOpens New Window

Associated Topics

Related Publications

Dabigatran versus warfarin for atrial fibrillation in real-world clinical practice: a systematic review and meta-analysis.

Romanelli RJ, Nolting L, Dolginsky M, Kym E, Orrico KB.
Circ Cardiovasc Qual Outcomes. pii: CIRCOUTCOMES.115.002369. [Epub ahead of print]
2016 Jan 26

Effect of long-term antibiotic use on weight in adolescents with acne.

Contopoulos-Ioannidis DG, Ley C, Wang W, Ma T, Olson C, Shi X, Luft HS, Hastie T, Parsonnet J.
J Antimicrob Chemother. pii: dkv455. [Epub ahead of print]
2016 Jan 17

Patient-initiated electronic messages and quality of care for patients with diabetes and hypertension in a large fee-for-service medical group: results from a natural experiment.

McClellan SR, Panattoni L, Chan AS, Tai-Seale M.
Med Care. [Epub ahead of print]
2016 Jan 12

Implementation of departmental quality strategies is positively associated with clinical practice: results of a multicenter study in 73 hospitals in 7 European countries.

Sunol R, Wagner C, Arah OA, Kristensen S, Pfaff H, Klazinga N, Thompson CA, Wang A, DerSarkissian M, Bartels P, Michel P, Groene O; DUQuE Project Consortium.
PLoS One. 10(11):e0141157. doi: 10.1371/journal.pone.0141157.
2015 Nov 20

Policy-oriented research on improved physician incentives for higher value health care.

Luft HS.
Health Serv Res. doi: 10.1111/1475-6773.12423. [Epub ahead of print]
2015 Nov 17